Honorio Benzon; James P. Rathmell; Christopher L. Wu; Dennis C. Turk; Charles E. Argoff; Robert W Hurley (11 de setembro de 2013). Practical Management of Pain. [S.l.]: Elsevier Health Sciences. ISBN978-0-323-17080-2
Calandre EP, Rico-Villademoros F, Slim M (2016). «Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use». Expert Rev Neurother. 16: 1263–1277. PMID27345098. doi:10.1080/14737175.2016.1202764
Dooley DJ, Taylor CP, Donevan S, Feltner D (2007). «Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission». Trends Pharmacol. Sci. 28: 75–82. PMID17222465. doi:10.1016/j.tips.2006.12.006
Zvejniece L, Vavers E, Svalbe B, Veinberg G, Rizhanova K, Liepins V, Kalvinsh I, Dambrova M (2015). «R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects». Pharmacol. Biochem. Behav. 137: 23–9. PMID26234470. doi:10.1016/j.pbb.2015.07.014
Vavers, Edijs; Zvejniece, Liga; Svalbe, Baiba; Volska, Kristine; Makarova, Elina; Liepinsh, Edgars; Rizhanova, Kristina; Liepins, Vilnis; Dambrova, Maija (2015). «The neuroprotective effects of R-phenibut after focal cerebral ischemia». Pharmacological Research. 113: 796–801. ISSN1043-6618. PMID26621244. doi:10.1016/j.phrs.2015.11.013
Vinik, Aaron; Rosenstock, Julio; Sharma, Uma; Feins, Karen; Hsu, Ching; Merante, Domenico (2014). «Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study». Diabetes Care. 37: 3253–61. PMID25231896. doi:10.2337/dc14-1044
nih.gov
ncbi.nlm.nih.gov
Calandre EP, Rico-Villademoros F, Slim M (2016). «Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use». Expert Rev Neurother. 16: 1263–1277. PMID27345098. doi:10.1080/14737175.2016.1202764
Dooley DJ, Taylor CP, Donevan S, Feltner D (2007). «Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission». Trends Pharmacol. Sci. 28: 75–82. PMID17222465. doi:10.1016/j.tips.2006.12.006